BrainStorm Cell Therapeutics' (BCLI) CEO Chaim Lebovits on Q2 2017 Results - Earnings Call TranscriptSeeking Alpha2 days ago
BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q2 2017 Results Earnings Conference Call August 16, 2017, 08:30 AM ET Executives Michael Wood - Chaim Lebovits -
- PR Newswire via Yahoo Finance3 days ago
(BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced financial results for the second quarter ending June 30, 2017. "We are in the advanced ...
- ACCESSWIRE via Yahoo Finance2 days ago
NEW YORK, NY / ACCESSWIRE / August 16, 2017 / Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) will be discussing their earnings results in their Q2 Earnings Call to be ...
Immune Pharmaceuticals Appoints Tony Fiorino, MD, PhD as Chief Medical Officer and Chief Operating OfficerBusiness Wire via Yahoo Finance4 days ago
Fiorino was the Chief Executive Officer of BrainStorm Cell Therapeutics (BCLI) a leading developer of adult stem cell technologies for neurodegenerative diseases.